Ajou University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Suwon United States (1973)

Organization Overview

First Clinical Trial
2007
NCT01820728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ajoun university hospital | Ajou University | Ajou University Hospital, Korea | Ajou University Hospital of Korea | Ajou University Hospital, Psychiatry | Ajou University Hospital, Suwon, Gyeongki-do, Korea | Ajou University Hospital, Suwon, Gyeongki-do, Korea, | Ajou University Hospital, Suwon, Gyeongki-do, South Korea, 443-721 | Ajou university hospotal | Ajou University Medical Center | Ajou University Medical Center, Suwon, Kyunggi-do, Korea, Republic of | Ajou University Medical Centre | Ajou University School of Medicine | Ajou Universiy School of Medicine | Ajou unversity medical center | Aju University Hospital | AJU University Hospital | Cardiovascular Center, Ajou University Hospital | Department of medicine, Ajou University School of Medicine | Department of surgery, Ajou University School of Medicine | Jin Soon Hwang

Active Ingredients

Drugs in Phase 4 Trials (54)

5,7-dihydroxy-3',4',6-trimethoxyflavone (2 trials)

acetylsalicylic acid (aspirin) (5 trials)

atenolol (tenormin) (1 trial)

atropine (2 trials)

basiliximab (Simulect) (2 trials)

bismuth (1 trial)

budesonide (rhinocort) (1 trial)

cilostazol (pletal) (2 trials)

clopidogrel (plavix) (4 trials)

cyclopropylmethylscopolamine (1 trial)

cyproviron (1 trial)

deflazacort (emflaza) (1 trial)

desflurane (suprane) (2 trials)

dexmedetomidine (precedex) (5 trials)

entecavir (baraclude) (2 trials)

ephedrine (1 trial)

escitalopram (lexapro) (1 trial)

fentanyl (Innovar) (2 trials)

fimasartan (kanarb) (3 trials)

glimepiride (amaryl) (2 trials)

haloperidol (haldol) (1 trial)

hifenac (1 trial)

ibuprofen (motrin) (1 trial)

imatinib (gleevec) (1 trial)

ingenol mebutate (picato) (1 trial)

insulin human (humulin) (1 trial)

ketamine (ketalar) (3 trials)

lamivudine (epivir) (1 trial)

leuprolide (lupron) (2 trials)

methylprednisolone (medrol) (2 trials)

metronidazole (flagyl) (1 trial)

misoprostol (cytotec) (1 trial)

montelukast (singulair) (2 trials)

mycophenolate (CellCept) (4 trials)

nateglinide (starlix) (1 trial)

omeprazole (prilosec) (2 trials)

palonosetron (aloxi) (2 trials)

pentoxifylline (trental) (1 trial)

phloroglucinol (1 trial)

pitavastatin (livalo) (1 trial)

prednisone (meticorten) (3 trials)

pregabalin (lyrica) (1 trial)

propofol (diprivan) (7 trials)

rebamipide (2 trials)

remifentanil (ultiva) (17 trials)

rocuronium (zemuron) (3 trials)

ropivacaine (naropin) (4 trials)

sevoflurane (ultane) (5 trials)

sitagliptin (januvia) (2 trials)

sodium chloride (8 trials)

tacrolimus (prograf) (4 trials)

thiopental (pentothal) (1 trial)

ticagrelor (brilinta) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (20)

agsct101 (1 trial)

allogeneic adipose derived mesenchymal stem cell (1 trial)

amlodipine (norvasc) (4 trials)

besifovir (1 trial)

candesartan (atacand) (3 trials)

carvedilol (coreg) (1 trial)

celecoxib (celebrex) (1 trial)

ckd-825 (1 trial)

follitropin alfa (Gonal-F) (1 trial)

human placenta hydrolysate (1 trial)

hydrochlorothiazide (esidrix) (2 trials)

immune globulin (human) (Gamastan) (2 trials)

losartan (cozaar) (2 trials)

moxifloxacin (avelox) (1 trial)

olmesartan (benicar) (1 trial)

recoflavone (1 trial)

somatropin (protropin) (3 trials)

tenofovir (viread) (1 trial)

vitamin d3 (1 trial)

zabofloxacin (1 trial)

Drugs in Phase 2 Trials (15)

allogeneic plx-pad cells (1 trial)

belotecan (1 trial)

cellulose (1 trial)

dienogest (natazia) (1 trial)

epoetin (Epogen) (2 trials)

gemcitabine (gemzar) (1 trial)

human immunoglobulin g (1 trial)

metformin (glucophage) (1 trial)

msc11fcd (1 trial)

Nelonemdaz (1 trial)

paclitaxel (taxol) (1 trial)

si000413 (1 trial)

sulodexide (Aterina) (1 trial)

temozolomide (temodar) (1 trial)

topotecan (hycamtin) (1 trial)

Drugs in Phase 1 Trials (9)

alendronic acid (fosamax) (1 trial)

metoprolol (lopressor) (1 trial)

omalizumab (xolair) (2 trials)

oxycodone (oxycontin) (2 trials)

pravastatin (pravachol) (1 trial)

sarpogrelate (1 trial)

simvastatin (zocor) (1 trial)

sodium bicarbonate (1 trial)

yh35324 (2 trials)

Drugs in Other Trials (12)

carbon dioxide (dry ice) (2 trials)

etomidate (amidate) (1 trial)

glycopyrronium (robinul) (3 trials)

lidocaine (xylocaine) (3 trials)

magnesium sulfate (Tis-U-Sol) (2 trials)

neostigmine (bloxiverz) (5 trials)

petrolatum, white (Vaseline) (1 trial)

polylactic acid (1 trial)

proparacetamol (1 trial)

remimazolam (Byfavo) (3 trials)

sugammadex (bridion) (5 trials)

ulinastatin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Alzheimer Disease (Phase 4)

Angina, Stable (Phase 4)

Angina, Unstable (Phase 4)

Anovulation (Phase 3)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Asthma (Phase 4)

Atrial Fibrillation (Phase 3)

Birth Weight (Phase 2)

Bradycardia (Phase 4)

Brain Ischemia (Phase 4)

Brain Neoplasms (Phase 2)

Bronchopulmonary Dysplasia (Phase 2)

Cerebral Infarction (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Depression (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 3)

Diabetic Retinopathy (Phase 2)

Disease (Phase 4)

Dwarfism (Phase 3)

Dyslipidemias (Phase 1)

Emergence Delirium (Phase 4)

Endometriosis (Phase 2)

Essential Hypertension (Phase 3)

Fatigue (Phase 3)

Fatigue Syndrome, Chronic (Phase 3)

Foot Ulcer (Phase 3)

Gastritis (Phase 4)

Gastroesophageal Reflux (Phase 1)

Glioblastoma (Phase 2)

Gliosarcoma (Phase 2)

Glomerulonephritis (Phase 3)

Gonadal Dysgenesis (Phase 3)

Heart Diseases (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 3)

Hernia, Inguinal (Phase 4)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hypertension (Phase 3)

IgG Deficiency (Phase 3)

Infertility (Phase 3)

Intermittent Claudication (Phase 2)

Ischemia (Phase 4)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)

Leukemia, Myeloid (Phase 4)

Liver Diseases (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 2)

Moyamoya Disease (Phase 2)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 2)

Neoplasms, Germ Cell and Embryonal (Phase 2)

Neovascularization, Pathologic (Phase 2)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Osteoporosis (Phase 1)

Peripheral Arterial Disease (Phase 2)

Prediabetic State (Phase 4)

Premature Birth (Phase 2)

Proteinuria (Phase 4)

Psychomotor Agitation (Phase 4)

Puberty, Precocious (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Retinal Diseases (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stomach Ulcer (Phase 1)

Stroke (Phase 4)

Syndrome (Phase 4)

Torticollis (Phase 4)

Turner Syndrome (Phase 3)

Ulcer (Phase 3)

Vitamin D Deficiency (Phase 3)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 127
  • # of Trial APIs: 110